StocksFundsScreenerSectorsWatchlists
CNC

CNC - Centene Corp Stock Price, Fair Value and News

70.74USD-0.90 (-1.26%)Market Closed

Market Summary

CNC
USD70.74-0.90
Market Closed
-1.26%

CNC Stock Price

View Fullscreen

CNC RSI Chart

CNC Valuation

Market Cap

37.8B

Price/Earnings (Trailing)

14

Price/Sales (Trailing)

0.25

EV/EBITDA

7.04

Price/Free Cashflow

5.22

CNC Price/Sales (Trailing)

CNC Profitability

EBT Margin

2.34%

Return on Equity

10.46%

Return on Assets

3.19%

Free Cashflow Yield

19.17%

CNC Fundamentals

CNC Revenue

Revenue (TTM)

154.0B

Rev. Growth (Yr)

10.96%

Rev. Growth (Qtr)

3.73%

CNC Earnings

Earnings (TTM)

2.7B

Earnings Growth (Yr)

121.13%

Earnings Growth (Qtr)

-90.41%

Breaking Down CNC Revenue

Last 7 days

-2.8%

Last 30 days

-7.8%

Last 90 days

-10.2%

Trailing 12 Months

2.0%

How does CNC drawdown profile look like?

CNC Financial Health

Current Ratio

1.11

Debt/Equity

0.69

Debt/Cashflow

0.45

CNC Investor Care

Buy Backs (1Y)

2.98%

Diluted EPS (TTM)

4.94

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2023146.3B147.9B150.1B154.0B
2022133.2B138.1B141.6B144.5B
2021115.1B118.4B121.7B126.0B
202082.2B91.6B101.7B111.1B
201965.4B69.5B72.3B74.6B
201849.9B52.1B56.4B60.1B
201745.4B46.4B47.5B48.4B
201624.6B30.0B35.0B40.6B
201518.2B19.7B21.2B22.8B
201411.8B13.2B14.8B16.6B
20139.1B9.7B10.2B10.9B
20125.7B6.3B7.3B8.1B
20114.6B4.8B5.0B5.3B
20104.2B4.3B4.4B4.4B
200903.6B3.9B4.1B
20080003.4B

Tracking the Latest Insider Buys and Sells of Centene Corp

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Apr 01, 2024
casso katie
sold (taxes)
-72,358
78.48
-922
corporate controller & cao
Mar 31, 2024
eppinger frederick h
acquired
-
-
323
-
Mar 31, 2024
samuels theodore r. ii
acquired
-
-
323
-
Mar 31, 2024
deveydt wayne s
acquired
-
-
420
-
Mar 31, 2024
coughlin christopher j
acquired
-
-
388
-
Mar 31, 2024
burdick kenneth a
acquired
-
-
388
-
Mar 15, 2024
asher andrew lynn
acquired
-
-
91,305
chief financial officer
Mar 15, 2024
smith susan raye
acquired
-
-
21,039
chief operating officer
Mar 15, 2024
fasola kenneth j
sold (taxes)
-473,944
76.05
-6,232
president
Mar 15, 2024
koster christopher
acquired
-
-
37,147
secretary & general counsel

1–10 of 50

Which funds bought or sold CNC recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Apr 11, 2024
Radnor Capital Management, LLC
unchanged
-
53,000
969,000
0.16%
Apr 11, 2024
Ballentine Partners, LLC
added
7.57
65,010
537,431
0.01%
Apr 11, 2024
Fortitude Family Office, LLC
unchanged
-
969
17,815
0.01%
Apr 11, 2024
OPTIMUM INVESTMENT ADVISORS
unchanged
-
12,810
235,440
0.11%
Apr 11, 2024
Gulf International Bank (UK) Ltd
added
0.76
219,000
3,558,000
0.09%
Apr 11, 2024
City State Bank
unchanged
-
3,000
55,000
0.02%
Apr 11, 2024
RFG Advisory, LLC
reduced
-0.06
63,575
1,180,730
0.04%
Apr 11, 2024
Running Oak Capital LLC
added
14.8
1,682,310
9,541,520
1.53%
Apr 11, 2024
SALEM INVESTMENT COUNSELORS INC
unchanged
-
3,049
56,035
-%
Apr 11, 2024
CHURCHILL MANAGEMENT Corp
added
1.9
900,338
12,500,400
0.16%

1–10 of 50

Are Funds Buying or Selling CNC?

Are funds buying CNC calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own CNC
No. of Funds

Unveiling Centene Corp's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
vanguard group inc
11.45%
61,190,588
SC 13G/A
Feb 09, 2024
capital world investors
5.5%
29,150,898
SC 13G/A
Feb 09, 2024
fmr llc
-
0
SC 13G/A
Jan 26, 2024
blackrock inc.
7.6%
40,819,347
SC 13G/A
Feb 13, 2023
capital world investors
8.8%
49,809,061
SC 13G/A
Feb 09, 2023
fmr llc
-
0
SC 13G/A
Feb 09, 2023
vanguard group inc
11.52%
65,260,984
SC 13G/A
Jan 31, 2023
blackrock inc.
7.2%
40,669,044
SC 13G/A
Feb 14, 2022
price t rowe associates inc /md/
4.9%
28,709,382
SC 13G/A
Feb 11, 2022
capital world investors
8.0%
46,851,859
SC 13G/A

Recent SEC filings of Centene Corp

View All Filings
Date Filed Form Type Document
Apr 03, 2024
PX14A6G
PX14A6G
Apr 02, 2024
4
Insider Trading
Apr 02, 2024
4
Insider Trading
Apr 02, 2024
4
Insider Trading
Apr 02, 2024
4
Insider Trading
Apr 02, 2024
4
Insider Trading
Apr 02, 2024
4
Insider Trading
Mar 29, 2024
8-K
Current Report
Mar 29, 2024
DEFA14A
DEFA14A
Mar 28, 2024
DEF 14A
DEF 14A

Peers (Alternatives to Centene Corp)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
404.6B
371.6B
-10.06% -16.60%
18.08
1.09
14.64% 11.24%
102.3B
195.3B
0.36% 32.66%
19.05
0.52
8.17% -20.79%
86.4B
357.8B
-8.56% -8.98%
10.34
0.24
10.95% 93.52%
85.4B
65.0B
0.28% 18.07%
16.29
1.31
7.86% -7.11%
37.8B
154.0B
-7.79% 1.99%
14
0.25
6.54% 124.79%
11.6B
14.3B
-4.37% 22.44%
16.11
0.81
6.59% 6.24%
11.4B
12.1B
-5.66% 54.55%
16.54
0.94
4.57% 23.40%
MID-CAP
9.4B
2.3B
-4.31% 9.94%
34.32
4.13
6.06% 9.17%
6.8B
2.9B
-6.65% -2.97%
-311.58
2.31
12.20% -107.93%
2.3B
1.4B
-0.51% 1.54%
37.23
1.63
21.19% 34.42%
2.1B
3.8B
-4.61% -35.19%
10.19
0.57
-27.73% -52.50%
SMALL-CAP
1.6B
1.1B
-1.23% -12.42%
25.41
1.5
11.31% 35.83%
1.2B
3.0B
4.69% 55.53%
-6.48
0.41
6.74% 20.73%
51.1M
-
-15.28% -9.77%
-3.49
-
- -12.94%
18.5M
21.3M
10.98% 5.02%
34.8
0.87
8.00% -62.25%

Centene Corp News

Latest updates
Defense World83 minutes ago
Yahoo Canada Finance08 Apr 202401:40 pm
Yahoo Finance18 Mar 202407:00 am

Centene Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue3.7%39,46038,04237,60838,88935,56135,86535,93637,18532,56832,40631,02529,98328,28829,09027,71226,02518,86318,97618,35618,44416,559
Costs and Expenses6.3%39,65437,30736,43737,67135,84335,38936,06535,93231,96531,86131,44328,92928,27328,22925,69425,83718,58618,80017,71317,75916,171
  S&GA Expenses14.4%3,4883,0483,0163,0113,1982,8462,8002,7452,6912,5372,1392,2342,2342,5072,2552,3841,7331,6171,5741,6091,556
EBITDA Margin-3.6%0.04*0.04*0.04*0.03*0.03*0.03*0.03*0.03*0.03*0.02*0.02*0.05*0.04*0.05*-------
Interest Expenses1.1%18318118118017416916216016217016317017718418718011399.0010199.0098.00
Income Taxes-105.1%-15.00293360261260269-65.00296101139-7.00244-55.0020774285.0058.0079.00170166116
Earnings Before Taxes-96.9%24.007681,4151,39141.001,009-2361,148694720-542941-74.007721,944131260175662685357
EBT Margin-3.0%0.02*0.02*0.03*0.02*0.01*0.02*0.02*0.02*0.01*0.01*0.01*0.03*0.02*0.03*-------
Net Income-90.4%45.004691,0581,130-213738-172849599584-535699-12.005681,20646.0020995.00495522241
Net Income Margin7.8%0.02*0.02*0.02*0.01*0.01*0.01*0.01*0.01*0.01*0.01*0.01*0.02*0.02*0.02*-------
Free Cashflow-100.7%-6.008852,3314,044-1,8093,0853,0729094271,5771,435-1442,775-1,203-------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets0.3%84,64184,38182,85382,98276,87081,17281,06082,90178,37577,74371,53970,28568,71968,36468,34766,43140,99434,25234,36833,56930,901
  Current Assets-1.6%40,75641,40534,86635,00930,12833,27532,40631,11028,49728,05625,46424,44023,39327,27526,82224,69620,32313,45713,59613,61611,998
    Cash Equivalents-5.5%17,19318,19017,17015,85312,07414,98713,43511,23713,11813,42311,0189,62710,95712,19812,7989,30812,1316,2156,8756,3455,350
  Net PPE0.7%2,0192,0042,4162,4782,4322,4792,5573,5833,3913,3022,9122,8222,7742,6692,5442,4392,1211,9931,8781,8001,706
  Goodwill0%17,55817,55818,71618,83618,81220,04020,31020,90319,77119,69918,80518,78818,65217,96417,43417,4176,8636,8727,1266,9817,015
Liabilities-0.5%58,68558,96557,06657,79652,63355,57254,49755,47151,35351,06945,41143,74942,75742,48543,14242,73928,30221,81622,09821,92519,878
  Current Liabilities-0.4%36,71636,85131,30632,85728,46431,33029,08629,68525,76525,04223,64222,27921,58521,79521,91821,65112,93213,28012,65313,14311,971
  Long Term Debt-1.0%17,71017,88817,89618,22317,93818,08418,45618,64018,57118,59416,53616,69516,68216,73716,70817,15013,6386,9757,0476,7756,648
    LT Debt, Current5.3%11911311097.0082.0024930029226724525362.0097.0089.0010612988.0066.0087.0040.0038.00
    LT Debt, Non Current-1.0%17,71017,88817,89618,22317,93818,08418,45618,64018,57118,59416,53616,69516,68216,73716,70817,15013,6386,9757,0476,7756,648
Shareholder's Equity2.2%25,84025,29525,76825,16624,05725,53426,43027,31326,94026,59026,04526,45825,88525,84325,17223,65612,65912,40512,24811,63411,013
  Retained Earnings0.4%12,04311,99811,52910,4719,3419,5548,8168,9888,1397,5406,9567,4916,7926,8046,2365,0304,9844,7754,6804,1853,663
  Additional Paid-In Capital0.3%20,30420,24320,18320,12120,06019,77419,89919,83019,67219,59419,54519,50019,45919,39019,33319,2797,6477,5717,5317,4917,449
Shares Outstanding0.0%534535546552551574583583583583582582571568-------
Minority Interest-3.0%97.0010097.0012412415614114414512413411611211811610710894.0094.0094.0096.00
Float---36,800---49,200---42,500---36,800---21,700--
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Quarterly)
(In Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations-78.7%2171,0212,5464,269-1,5763,3323,3541,1516751,8021,68543.002,981-9523,714-240-651-99.009171,316-634
  Share Based Compensation-2.0%49.0050.0056.0061.0054.0051.0059.0070.0076.0040.0036.0051.0063.0054.0047.0011771.0034.0034.0038.0040.00
Cashflow From Investing-318.2%-949435-424-2532213.00-744-2,401-857-1,022-813-607-4,255332240-3,272-144-459-556-373-1,022
Cashflow From Financing61.6%-201-524-750-183-1,732-1,481-486-498-2351,64327.00-73.00-1234.00-4608396,704-10817858.00152
  Buy Backs-96.0%31.007744054231,4331,24334971.0024816.004.0029.0056.009.003.0055834.004.002.0035.0054.00

CNC Income Statement

2023-12-31
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Revenues:   
Revenues$ 140,095$ 135,479$ 117,983
Premium tax13,9049,0687,999
Total revenues153,999144,547125,982
Expenses:   
Medical costs118,894111,52998,602
Cost of services3,5647,0324,894
Selling, general and administrative expenses12,56311,5899,601
Depreciation expense575614565
Amortization of acquired intangible assets718817770
Premium tax expense14,2269,3308,287
Impairment5292,318229
Legal settlement001,250
Total operating expenses151,069143,229124,198
Earnings from operations2,9301,3181,784
Other income (expense):   
Investment and other income1,3931,279819
Debt extinguishment030(125)
Interest expense(725)(665)(665)
Earnings before income tax3,5981,9621,813
Income tax expense899760477
Net earnings2,6991,2021,336
Loss attributable to noncontrolling interests3011
Net earnings attributable to Centene Corporation$ 2,702$ 1,202$ 1,347
Net earnings per common share attributable to Centene Corporation:   
Basic earnings per common share (in usd per share)$ 4.97$ 2.09$ 2.31
Diluted earnings per common share (in usd per share)$ 4.95$ 2.07$ 2.28
Weighted average number of common shares outstanding:   
Basic (in shares)543,319575,191582,832
Diluted (in shares)545,704582,040590,516
Premium   
Revenues:   
Revenues$ 135,636$ 127,131$ 112,319
Service   
Revenues:   
Revenues$ 4,459$ 8,348$ 5,664

CNC Balance Sheet

2023-12-31
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 17,193$ 12,074
Premium and trade receivables15,53213,272
Short-term investments2,4592,321
Other current assets5,5722,461
Total current assets40,75630,128
Long-term investments16,28614,684
Restricted deposits1,3861,217
Property, software and equipment, net2,0192,432
Goodwill17,55818,812
Intangible assets, net6,1016,911
Other long-term assets5352,686
Total assets84,64176,870
Current liabilities:  
Medical claims liability18,00016,745
Accounts payable and accrued expenses16,4209,525
Return of premium payable1,4621,634
Unearned revenue715478
Current portion of long-term debt11982
Total current liabilities36,71628,464
Long-term debt17,71017,938
Deferred tax liability641615
Other long-term liabilities3,6185,616
Total liabilities58,68552,633
Commitments and contingencies
Redeemable noncontrolling interests1956
Stockholders' equity:  
Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at December 31, 2023 and December 31, 202200
Common stock, $0.001 par value; authorized 800,000 shares; 615,291 issued and 534,484 outstanding at December 31, 2023, and 607,847 issued and 550,754 outstanding at December 31, 202211
Additional paid-in capital20,30420,060
Accumulated other comprehensive (loss)(652)(1,132)
Retained earnings12,0439,341
Treasury stock, at cost (80,807 and 57,093 shares, respectively)(5,856)(4,213)
Total Centene stockholders' equity25,84024,057
Nonredeemable noncontrolling interest97124
Total stockholders' equity25,93724,181
Total liabilities, redeemable noncontrolling interests and stockholders' equity$ 84,641$ 76,870
CNC
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. It operates in two segments, Managed Care and Specialty Services. The Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs. This segment also provides a variety of individual, small group, and large group commercial healthcare products to employers and members. This segment also offers various individual, small group, and large group commercial healthcare products to employers and members. The Specialty Services segment offers behavioral health and employee assistance plans; clinical healthcare, primary care, various specialty services, and a suite of social and other support services; data analytics solutions; administrative services to Military Health System eligible beneficiaries; traditional pharmacy clinical and administrative services as well as specialized pharmacy benefit services through its specialty pharmacy business; and vision and dental health services. This segment provides auxiliary healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations; and engages in the government contracts business under the TRICARE program and other healthcare related government contracts. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.
 CEO
 WEBSITEcentene.com
 INDUSTRYHealthcare Plans
 EMPLOYEES65535

Centene Corp Frequently Asked Questions


What is the ticker symbol for Centene Corp? What does CNC stand for in stocks?

CNC is the stock ticker symbol of Centene Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Centene Corp (CNC)?

As of Fri Apr 12 2024, market cap of Centene Corp is 37.84 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CNC stock?

You can check CNC's fair value in chart for subscribers.

What is the fair value of CNC stock?

You can check CNC's fair value in chart for subscribers. The fair value of Centene Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Centene Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for CNC so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Centene Corp a good stock to buy?

The fair value guage provides a quick view whether CNC is over valued or under valued. Whether Centene Corp is cheap or expensive depends on the assumptions which impact Centene Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CNC.

What is Centene Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Apr 12 2024, CNC's PE ratio (Price to Earnings) is 14 and Price to Sales (PS) ratio is 0.25. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CNC PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Centene Corp's stock?

In the past 10 years, Centene Corp has provided 0.172 (multiply by 100 for percentage) rate of return.